Homemavenclad

  • Additional Cladribine data reinforces efficacy in RMS patients

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mavenclad has even greater treatment effect in Patients with Highly Active Multiple Sclerosis, shows latest data

    • May 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMD Serono Highlights Commitment to Advance MS Treatment with Investigational Cladribine Tablets and Rebif® Data at AAN 2018

    • April 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mavenclad (cladribine) approved for Active RMS in UAE

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more